DMK PHARMACEUTICALS CORPORATION: cashflow_financing
| Value | {"amount": 5105876, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2010-04-01 – 2011-03-31 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:22.688453+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cae69b2d-dd06-4d3b-9bdd-ff5b79d88a5e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-12-002016 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:22.688453+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/cashflow-financing/2011-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cae69b2d-dd06-4d3b-9bdd-ff5b79d88a5e
History
- no predecessors — first report